Assoc. Prof. Dr. Álvaro Castellanos, HOSPITAL UNIVERSITARIO Y POLITÉCNICO LA FE DE VALENCIA, Spain

Dr. Álvaro Castellanos Ortega is a highly esteemed Associate Professor of Medicine and the Head of the Intensive Care Department at Hospital Universitario y Politécnico La Fe in Valencia. He earned his Medical degree from the University of Valladolid and completed his PhD at the University of Cantabria. With extensive expertise in intensive care and medical education, Dr. Castellanos has contributed significantly to research in infection, sepsis, and training. He has authored 63 indexed publications, and his work on competence-based medical education has earned multiple prestigious awards, including the ESICM Trials Group Award. He is also actively involved in European medical education initiatives.

Publication Profile

Orcid

Professional Qualifications 🏥

Assoc. Prof. Dr. Álvaro Castellanos is a distinguished medical professional with a strong academic and clinical background. He graduated in Medicine and Surgery from the University of Valladolid (1979) and earned his PhD with honors from the University of Cantabria (1998), focusing on a prognostic scoring system for meningococcal septic shock in children. He specialized in Intensive Care Medicine, completing his training at Hospital Universitario Marqués de Valdecilla. Dr. Castellanos serves as Head of the Intensive Care Medicine Department at Hospital Universitario y Politécnico La Fe de Valencia. He is also an Associate Professor at the University of Valencia and an EDIC examiner. Additionally, he holds a Master’s in Healthcare Administration from the University of Cantabria. 🌟

Awards and Recognitions

Assoc. Prof. Dr. Álvaro Castellanos has earned numerous prestigious awards throughout his career. He won the First Prize for Quality Improvement of Care from the Regional Healthcare Service of Cantabria in 2008. His initiative on implementing the Surviving Sepsis Campaign during residency also received recognition. In 2017, he earned the First Prize for Best Patient Safety Initiatives for his rapid response system project. Dr. Castellanos was awarded the Best Project in Postgraduate Teaching by the Lilly Foundation for his electronic portfolio for specialists. Additionally, he received the ESICM Trials Group Award for his research on medical education in intensive care. 🌟

Research Focus

Dr. Álvaro Castellanos-Ortega is an Associate Professor with significant contributions in intensive care medicine, particularly related to medical education and patient safety in critically ill patients. He has been involved in multiple research projects focusing on pharmacokinetics in critically ill patients, including studies on Cefiderocol, Isavuconazole, and other medications. Dr. Castellanos-Ortega has authored and co-authored numerous articles on intensive care topics such as COVID-19 management, heart transplantation, and training programs for intensive care medicine. His work is widely published in journals like Medicina Intensiva and Critical Care, contributing significantly to the improvement of clinical practices in intensive care units.

Publication Top Notes

Effect of a Competence-Based Medical Education Program on Training Quality in Intensive Care Medicine. COBALIDATION TRIAL.
Medicina Intensiva (2025-01-03)
DOI: 10.1016/j.medine.2024.502126
PMID: 39755447
Contributors: Castellanos-Ortega Á, Broch Porcar MJ, Palacios-Castañeda D, et al.
Cefiderocol Pharmacokinetics in Critically Ill Patients Undergoing ECMO Support.
Critical Care (2024-10-18)
DOI: 10.1186/s13054-024-05126-4
PMID: 39425201
PMC: PMC11488226
Contributors: Marín-Cerezuela M, Martín-Latorre R, Frasquet J, et al.
Reply to “Patient Safety, What Does Clinical Simulation and Teaching Innovation Contribute?”
Medicina Intensiva (2024-10-05)
DOI: 10.1016/j.medine.2024.07.013
PMID: 39368886
Contributors: Broch Porcar MJ, Castellanos-Ortega Á
Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends Over Time.
Biomedicines (2024-09-16)
DOI: 10.3390/biomedicines12092109
PMID: 39335622
PMC: PMC11428817
Contributors: López Vilella R, Pérez Guillén M, Borja Guerrero Cervera, et al.
Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
Antibiotics (2024-07-29)
DOI: 10.3390/antibiotics13080706
PMID: 39200006
PMC: PMC11350865
Contributors: Martín Cerezuela M, Gallegos C, Marqués-Miñana MR, et al.
Patient Safety, What Does Clinical Simulation and Teaching Innovation Contribute?
Medicina Intensiva (2024-05-25)
DOI: 10.1016/j.medine.2024.04.012
PMID: 38797620
Contributors: Broch Porcar MJ, Castellanos-Ortega Á
“INTUPROS”: An Opportunity to Reflect Upon and Improve.
Medicina Intensiva (2024-05-06)
DOI: 10.1016/j.medine.2024.04.014
PMID: 38714391
Contributors: Viviani A, Vicent C, Castellanos-Ortega Á
Mentoring Programme: Guiding Your First Steps Towards Scientific Excellence.
Medicina Intensiva (2023-03-21)
DOI: 10.1016/j.medine.2023.03.006
PMID: 36948924
Contributors: Lobo-Valbuena B, Galarza Barrachina L, Albillos Almaraz R, et al.
Effects of Intubation Timing in Patients with COVID-19 Throughout the Four Waves of the Pandemic: A Matched Analysis.
The European Respiratory Journal (2023-03-02)
DOI: 10.1183/13993003.01426-2022
PMID: 36396142
PMC: PMC9686319
Contributors: Riera del Brio J, Barbeta E, Tormos A, et al.
Driving Pressure and Adjunctive Therapies in Pulmonary Sequelae of COVID-19 Patients Under Invasive Ventilation.
Intensive Care Medicine (2023-01-25)
DOI: 10.1007/s00134-022-06951-3
PMID: 36695836
PMC: PMC9875751
Contributors: González J, Iván David Benítez, Ana Motos, et al.

Nazim Uzzaman | Medicine and Dentistry | Best Researcher Award | 12753

Posted on 06/01/202506/01/2025 by ScienceFather

Dr. Nazim Uzzaman | Medicine and Dentistry | Best Researcher Award

PhD Candidate at The University of Edinburgh, United Kingdom

Dr. Nazim Uzzaman is a researcher and academic with a focus on chronic respiratory diseases, including asthma, COPD, pulmonary rehabilitation, and digital health. He is currently pursuing a PhD at The University of Edinburgh and has a Master of Public Health from American International University–Bangladesh. Dr. Uzzaman has contributed to 17 research articles, with 7 as the lead author, and has been involved in 8 research projects, serving as Principal Investigator in two. His expertise includes systematic reviews, mixed-methods studies, focused ethnography, and implementation research. Dr. Uzzaman has received several awards, including Best Oral Presentation at the IPCRG World Conference and Best Scientific Research Poster at the PCRS Respiratory Conference. He is an active member of the European Respiratory Society and the International Primary Care Respiratory Group. Additionally, he serves as a peer reviewer for prestigious journals, further cementing his reputation in the research community.

Professional Profile :

Google Scholar
ORCID Profile

Education:

Dr. Nazim Uzzaman has a robust academic background in medicine and public health. He completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at Rajshahi Medical College in Bangladesh in 2010. Following this, he pursued a Master of Public Health (MPH) at American International University–Bangladesh, graduating in 2017. Currently, Dr. Uzzaman is a PhD candidate at The University of Edinburgh, where he is focusing on applied respiratory health research, with his thesis already submitted. His academic journey reflects a commitment to advancing his knowledge in both clinical medicine and public health, particularly in the area of chronic respiratory diseases. This combination of clinical and public health education provides him with a unique perspective on respiratory health research, equipping him to address complex healthcare challenges. Dr. Uzzaman’s academic achievements demonstrate his dedication to both research and practical applications in the medical field.

Professional Experience:

Dr. Nazim Uzzaman has extensive professional experience in both clinical and academic settings. He is currently a PhD student at The University of Edinburgh, where he is conducting research in respiratory applied health, focusing on chronic respiratory diseases such as asthma, COPD, and pulmonary rehabilitation. Dr. Uzzaman also serves as a part-time tutor for the Master of Family Medicine program and as a dissertation supervisor for the Master of Public Health program at the university. In addition, he is a Trial Manager for the Bangladesh site of a respiratory health project, where he oversees research operations. Previously, Dr. Uzzaman worked at icddr,b in Bangladesh, progressing from Clinical Fellow to Medical Officer, Clinical Trainer, and Training Physician, contributing to healthcare delivery and medical training. He has also worked as a General Practitioner at Green and Green Medical Services in Bangladesh, gaining hands-on experience in primary care and patient management.

Research Interest:

Dr. Nazim Uzzaman’s research interests lie primarily in the field of chronic respiratory diseases, with a focus on asthma, COPD, and pulmonary rehabilitation. He is particularly interested in exploring innovative solutions to improve patient outcomes through digital health technologies. His expertise spans systematic reviews, mixed-methods studies, focused ethnography, and implementation research, which he utilizes to assess and enhance healthcare interventions. Dr. Uzzaman’s work aims to bridge the gap between clinical practice and research, emphasizing the application of evidence-based strategies to improve care for individuals with respiratory conditions. Additionally, his research investigates the effectiveness of pulmonary rehabilitation programs and the integration of digital health tools to support self-management in patients with chronic respiratory diseases. His interdisciplinary approach and commitment to understanding the lived experiences of patients position him as a key contributor to advancing respiratory health research, with the ultimate goal of improving public health outcomes.

Award and Honor:

Dr. Nazim Uzzaman has received several prestigious awards and honors in recognition of his outstanding contributions to respiratory health research. He was awarded the Best Oral Presentation at the IPCRG World Conference in 2021, highlighting his ability to effectively communicate complex research findings. Additionally, he received the Best Scientific Research Poster award at the PCRS Respiratory Conference in the UK in 2019, further emphasizing his excellence in presenting innovative research in the field. Dr. Uzzaman was also honored with the RESPIRE Fellowship (2019–2020), a prestigious recognition that supports early-career researchers in global respiratory health. His academic and research accomplishments have been consistently acknowledged, with his work being featured in respected journals and conferences. These accolades reflect his commitment to advancing knowledge in chronic respiratory diseases and his growing influence within the global respiratory research community.

Conclusion:

Dr. Nazim Uzzaman has demonstrated a strong commitment to advancing research in respiratory health, particularly focusing on chronic diseases like asthma, COPD, and pulmonary rehabilitation, along with the integration of digital health solutions. With a robust academic background, including a PhD studentship at The University of Edinburgh and a Master of Public Health, Dr. Uzzaman has contributed significantly to the field through 17 published research articles and involvement in several high-impact projects. His leadership as Principal Investigator and Co-Investigator, coupled with his expertise in systematic reviews, mixed-methods studies, and implementation research, underscores his capability in driving impactful health research. Recognized for his scholarly work with multiple awards, including Best Oral Presentation and Best Scientific Research Poster, Dr. Uzzaman continues to make valuable contributions to the academic community. His ongoing work and professional involvement in global respiratory health organizations position him as a promising leader in clinical academic research.

Publication Top Notes :

Title: Systematic review of clinical effectiveness, components, and delivery of pulmonary rehabilitation in low-resource settings
Authors: GMM Habib, R Rabinovich, K Divgi, S Ahmed, SK Saha, S Singh, A Uddin, MN Uzzaman, …
Year: 2020
Citations: 46
Title: Effectiveness of home-based pulmonary rehabilitation: systematic review and meta-analysis
Authors: MN Uzzaman, D Agarwal, SC Chan, JP Engkasan, GMM Habib, …
Year: 2022
Citations: 40
Title: Continuing professional education for general practitioners on chronic obstructive pulmonary disease: feasibility of a blended learning approach in Bangladesh
Authors: MN Uzzaman, T Jackson, A Uddin, N Rowa-Dewar, MJ Chisti, …
Year: 2020
Citations: 32
Title: Correlates of climate variability and dengue fever in two metropolitan cities in Bangladesh
Authors: MZ Islam, S Rutherford, D Phung, MN Uzzaman, S Baum, MM Huda, …
Year: 2018
Citations: 30
Title: Engaging with stakeholders in a research programme to promote implementation of pulmonary rehabilitation in Bangladesh: Challenges and opportunities
Authors: GMM Habib, MN Uzzaman, P Malik, R Rabinovich, A Uddin, SMR Alam, …
Year: 2020
Citations: 12
Title: Clinical effectiveness and components of home-pulmonary rehabilitation for people with chronic respiratory diseases: a systematic review protocol
Authors: MN Uzzaman, SC Chan, RH Shunmugam, JP Engkasan, D Agarwal, …
Year: 2021
Citations: 9
Title: Prevalence of type 2 diabetes mellitus among urban Bihari communities in Dhaka, Bangladesh: a cross-sectional study in a minor ethnic group
Authors: M Asaduzzaman, S Chowdhury, JH Shahed, MAH Kafi, MN Uzzaman, …
Year: 2018
Citations: 9
Title: Characteristics of Rotavirus, ETEC, and Vibrio Cholerae among under 2-year children attending an urban diarrheal disease hospital in Bangladesh
Authors: MHR Sarker, M Moriyama, MM Rahman, SK Das, MN Uzzaman, J Das, …
Year: 2021
Citations: 8
Title: Village doctors: a national telephone survey of Bangladesh’s lay medical practitioners
Authors: O Muurlink, N Uzzaman, RJ Boorman, S Binte Kibria, T Best, …
Year: 2023
Citations: 4
Title: Beyond the regulatory radar: knowledge and practices of rural medical practitioners in Bangladesh
Authors: H Sujon, MHR Sarker, A Uddin, S Banu, MR Islam, MR Amin, MS Hossain, …
Year: 2023
Citations: 3
Title: Asynchronous digital health interventions for reviewing asthma: A mixed-methods systematic review protocol
Authors: MN Uzzaman, V Hammersley, K McClatchey, J Sheringham, GMM Habib, …
Year: 2023
Citations: 3
Title: Professional development of health researchers during the COVID-19 pandemic: challenges and prospects of synchronous online learning
Authors: H Sujon, MN Uzzaman, S Banu, MR Islam, M Asaduzzaman, A Ahmed, …
Year: 2022
Citations: 3
Title: Improving physicians’ capacity for chronic obstructive pulmonary disease care through blended e-learning: a pilot study in Bangladesh
Authors: MN Uzzaman, S Banu, GMM Habib, AHME Hossain, MJ Kabir, MR Karim, …
Year: 2018
Citations: 3
Title: Neonatal pneumonia in a rural primary care hospital in Bangladesh: prevalence, validation of clinical features and their outcome
Authors: MN Uzzaman, MAF Khan, T Ahmed, MHR Sarker, S Yeasmin, KN Saqeeb, …
Year: 2016
Citations: 1
Title: Effectiveness and Acceptability of Asynchronous Digital Health in Asthma Care: Mixed Methods Systematic Review
Authors: N Uzzaman, V Hammersley, K McClatchey, J Sheringham, D Singh, …
Year: 2024
Citations: N/A (Future publication)
Title: Exploring the perceptions of patients with chronic respiratory diseases and their insights into pulmonary rehabilitation in Bangladesh
Authors: GMM Habib, N Uzzaman, R Rabinovich, S Akhter, M Ali, M Sultana, …
Year: 2024
Citations: N/A (Future publication)
Title: Characteristics of pulmonary rehabilitation programmes and their effects on exercise capacity and quality of life in patients with interstitial lung diseases: a systematic …
Authors: J Jimenez, F Tahirah, N Uzzaman, R Hisham, N Zawani, H Pinnock, …
Year: 2023
Citations: N/A (Future publication)
Title: Asynchronous digital health interventions (aDHI) for reviewing asthma: a mixed-methods systematic review
Authors: N Uzzaman, V Hammersley, K McClatchey, J Sheringham, M Habib, …
Year: 2023
Citations: N/A (Future publication)
Title: Changing Water-Sanitation Determinants of Cholera over Two Decades in Bangladesh
Authors: MHR Sarker, SK Das, H Sujon, M Moriyama, MM Rahman, MN Uzzaman, …
Year: 2023
Citations: N/A (Future publication)
Title: Feasibility study of home-based pulmonary rehabilitation (PR) in Bangladesh
Authors: GMM Habib, R Rabinovich, N Uzzaman, K Nahar, S Akter, H Pinnock
Year: 2022
Citations: N/A (Future publication)

Tiantian Zhang | Health Professions | Best Researcher Award

Posted on 02/12/202402/12/2024 by ScienceFather

Dr. Tiantian Zhang | Health Professions | Best Researcher Award

Dr. Tiantian Zhang, Fudan University, China

Dr. Tiantian Zhang is a dedicated researcher in the field of public health, specializing in the construction of public health systems and proactive health technologies within the context of medical health big data. Currently serving as a Youth Researcher at the School of Public Health at Fudan University since October 2023, she brings an academic background with a Master’s and Doctorate in Management, focusing on social medicine and health management from Fudan University. She has contributed significantly to over 38 publications, with many in high-impact journals, particularly in health policy, public health emergency responses, and chronic disease prevention. Her research also covers the intersection of technology, public health, and healthcare systems. She has been involved in various research projects and has received substantial funding for her work. Dr. Zhang’s academic journey includes postdoctoral research and entrepreneurial experience in management science and data science. Additionally, she is a key member of national projects on public health and disease prevention.

Publication Profile

Scopus

Academic Background 🎓📚

Dr. Tiantian Zhang pursued her graduate studies at Fudan University, where she earned a Master’s degree in Management with a focus on Social Medicine and Health Administration from September 2016 to June 2018. 🏫🎓 She continued her academic journey at Fudan, completing a PhD in Management in the same field from June 2018 to June 2021. 🔬 Her doctoral research contributed to advancing public health management and policy, further establishing her expertise in healthcare systems and social medicine. Dr. Zhang’s academic foundation laid the groundwork for her current work in public health and health data research. 🌟📊

Professional and Visiting Scholar Experience 💼🌍

Dr. Tiantian Zhang has held various esteemed positions in her career. Since October 2023, she has been serving as a Youth Researcher at Fudan University, focusing on Health Management. 🏫🧑‍🔬 From June 2021 to September 2023, she worked as a Postdoctoral Researcher at Fudan University, specializing in Public Policy. 📜🔍 Additionally, since September 2017, Dr. Zhang has been the founder and legal representative of Shanghai Haiyu Information Technology Co., Ltd., where she applies her expertise in Management Science and Data Science. 💻📊 Her diverse roles reflect her commitment to advancing healthcare and policy through innovation. 🌟

Research Achievements and Contributions 📚🏆

Dr. Tiantian Zhang, a Youth Researcher at Fudan University’s School of Public Health, has made significant contributions to healthcare management research. She has co-authored 9 policy briefs, receiving positive feedback from top political leaders, including members of the Central Political Bureau. 👩‍🔬✨ She has led a National Natural Science Foundation Youth Project and 7 provincial projects, while also contributing to major national R&D initiatives. Her research includes 37 published papers, 8 of which are in high-impact journals (SCI/SSCI, JCR-Q1), with a total impact factor of 68.5. 📝📊 Dr. Zhang has received multiple prestigious awards, including the Shanghai Decision-Making Advisory Research Awards and the Shanghai Youth Medal. 🏅

Academic Positions and Editorial Roles 📚🌟

Dr. Tiantian Zhang holds several prestigious academic roles. She is a Youth Elite Talent for the Shanghai Municipal Government Decision-Making Consulting Research Base (2024–2026) and an expert in Shanghai’s healthcare reform (2022–2025). 🏅 She serves on the Youth Committee of the Shanghai Medical Association’s Health Management Branch and is a director of the Chinese Medicine Informatics Society. 🩺 Additionally, she contributes to several academic journals, including Chinese Hospital Management and Chinese Public Health Management, where she holds youth editorial board positions. ✍️ She is also involved in writing and editing key publications, including the fifth edition of Health Management and the Blue Book on Proactive Health and Healthy Aging. 📖

Research Focus

Dr. Tiantian Zhang’s research focuses on public health management, health policy, and health data science. She is particularly interested in the intersection of healthcare system development and technology for proactive health and aging. 🏥 Her work includes studies on health equity, air pollution, dyslipidemia, and disease prevention, and she frequently contributes to research on health disparities and socioeconomic factors affecting public health. 🌍 Additionally, she explores health management practices and decision-making frameworks for improving healthcare services, with a strong emphasis on government regulation and community-based health interventions. 📊

Publication Top Notes

Association of circadian syndrome with risk of hyperuricemia among middle-aged and older adults in China – 2025 🕰️,
Research on government regulation methods for the spatial layout of retail pharmacies – 2024 🏪
Prevalence of dyslipidemia and associated factors in sedentary occupational population from Shanghai – 2024 ⚖️,
Global Justice Index Report 2023 – 2024 🌍, Cited by: 2 📑.
Association of long-term exposure to air pollutants with sensory impairment in middle-aged and elderly adults – 2024 🌫️
Equity analysis of older adult resource allocation in China – 2024 💼
Development of an assessment tool for designated medical institutions in China – 2024 💻
Association of indoor solid fuel use and long-term exposure to ambient PM2.5 with sarcopenia in China – 2023 🌫️, Cited by: 10 📑.
Global Justice Index Report 2022 – 2023 🌍, Cited by: 7 📑.

Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award

Posted on 28/11/202428/11/2024 by ScienceFather

Prof. Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award

Prof. Fatmah Alasmary, Saudi Food and Drug Authority, Saudi Arabia

Professor at King Saud University, specializing in organic chemistry. Dr. Alasmary has extensive experience in academia and leadership, with a PhD from the University of Bradford. Currently, she serves as Director of the Drug Lab at the Saudi Food and Drug Authority. Her research interests include antimicrobial agents and nanomaterials. Dr. Alasmary has mentored numerous students and has held key roles in various scientific committees. She is a member of the Saudi Chemical Association, the Royal Society of Chemistry, and the American Chemical Society. 🧑‍🔬👩‍🏫🔬

Publication Profile

Google Scholar

Work Experience 🌍💼

Prof. Fatmahalasmary is a distinguished academic and professional, currently serving as the Director of Drug Lab at Saudi Food and Drug Authority, Riyadh. She oversees quality control, safety standards, and international accreditation efforts for medicines and cosmetics. As Chief of Senior Expert International Communication, she leads food standards initiatives for Saudi Arabia, managing ISO committees and Codex committees. Previously, she was Vice Chairman at King Saud University’s Chemistry Department, coordinating research, teaching, and international collaborations. Prof. Fatmahalasmary’s leadership spans teaching, curriculum development, and guiding postgraduate research, exemplifying excellence in both academic and professional spheres. 📚🌐👩‍🔬

Qualifications 🎓🌟

Prof. Fatmahalasmary holds a PhD in Chemistry from the University of Bradford, England (2013), where her thesis focused on the synthesis and evaluation of benzimidazole derivatives as potential antimicrobial agents. She earned a Master of Science in Chemistry from King Saud University, KSA (2008), with a thesis on the synthesis and study of quinoxaline derivatives. Additionally, she completed her Bachelor of Science in Chemistry at King Saud University, KSA (2001), graduating with honors. Her academic journey highlights a strong foundation in chemistry and a commitment to research excellence. 🧪📘👩‍🔬

Additional Experience 🌍🔬

Prof. Fatmahalasmary has actively participated in over 22 workshops focused on management, planning, and quality development. She is a member of several prestigious associations, including the Saudi Chemical Association, Royal Society of Chemistry, and American Chemical Society. Her roles have included coordinating committees at King Saud University (KSU), such as the Development and Quality Committee and Labs Committee. Prof. Fatmahalasmary has also been involved in thesis defenses, scientific symposia, and national exhibitions. She holds patents for innovative extracts and is certified in ISO 9001:2015 and as a Certified Innovation Professional. 📚💡📈

Research Focus

Prof. Fatmah Ali S Alasmary’s research spans various fields, including antimicrobial agents 🦠, biological chemistry 🧬, and medicinal chemistry 💊. She has contributed significantly to the development of benzimidazole derivatives as potential antimicrobial agents, as well as carbonic anhydrase inhibitors targeting various pathogens. Her work also delves into perovskite materials 🏗️, photocatalysis ⚛️, and nanomaterials 🧪 with applications in sensing and biomedical fields. Prof. Alasmary has been actively involved in computational studies of drug design 💻, enzyme inhibition 🧪, and therapeutic applications for diseases like malaria and cancer.

Publication Top Notes

Tin versus lead redox chemistry modulates charge trapping and self-doping in tin/lead iodide perovskites (186 citations, 2020) 🔋
Synthesis and evaluation of selected benzimidazole derivatives as potential antimicrobial agents (140 citations, 2015) 💊
Inhibition of the β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamates (41 citations, 2017) 🦠
Direct Access to α‐Aminosilanes Enabled by Visible‐Light‐Mediated Multicomponent Radical Cross‐Coupling (36 citations, 2021) 💡
Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3 H)-ones as … (35 citations, 2015) 🔬
Analysis of Alpina officinarum Hance, chemically and biologically (30 citations, 2019) 🌿
Combined computational and experimental investigation on the nature of hydrated iodoplumbate complexes: Insights into the dual role of water in perovskite precursor solutions (28 citations, 2020) 💧
The first activation studies of the η-carbonic anhydrase from the malaria parasite Plasmodium falciparum with amines and amino acids (28 citations, 2018) 🦠
New quinoxalinone inhibitors targeting secreted phospholipase A2 and α-glucosidase (28 citations, 2017) 🧪
Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach (27 citations, 2021) 🦠

Chun-Feng Huang | Health Professions | Best Researcher Award

Posted on 26/11/202426/11/2024 by ScienceFather

Assist. Prof. Dr. Chun-Feng Huang | Health Professions | Best Researcher Award

Chief of Family Medicine at En Chu Kong Hospital/National Yang Ming Chiao Tung University, Taiwan

Dr. Chun-Feng Huang is an Assistant Professor at the National Yang Ming Chiao Tung University and the Chief of Family Medicine at En Chu Kong Hospital. With a rich academic background, including a Ph.D. from Taipei Medical University and an MD from National Yang Ming Chiao Tung University, Dr. Huang is a certified expert in Family Medicine, Hospice and Palliative Medicine, and Osteoporosis. His research spans metabolomics, precision medicine, gerontology, and osteoporosis, with numerous publications in reputable journals. 🌊🔬.

Publication Profile

Education

Dr. Chun-Feng Huang earned his Doctor of Medicine degree from the National Yang Ming Chiao Tung University, School of Medicine, Taiwan. He further specialized by obtaining a Ph.D. from Taipei Medical University’s Graduate Institute of Clinical Medicine. Complementing his advanced education, Dr. Huang holds various board certifications: Family Medicine, Hospice and Palliative Medicine, Integrative Medicine, and Osteoporosis. Additionally, he is a Certified Clinical Densitometrist accredited by the International Society for Clinical Densitometry (ISCD). His academic journey reflects a deep commitment to continuous learning and specialization in both clinical and research domains, equipping him with a robust foundation to tackle complex medical challenges. Dr. Huang’s educational background not only highlights his expertise in medicine but also underscores his dedication to advancing patient care through education, research, and clinical excellence.

Experience

Dr. Chun-Feng Huang’s career is marked by influential roles in academia and clinical practice. He currently serves as an Assistant Professor at the National Yang Ming Chiao Tung University and Chief of the Department of Family Medicine at En Chu Kong Hospital. Previously, he directed the Department of Family Medicine at the same university hospital from 2016 to 2022. His leadership extended to chairing healthcare services for correctional institutions and community development associations. As Deputy Secretary General and former Prevention Committee Deputy Chairman of the Taiwan Association of Family Medicine, Dr. Huang has shaped national health policies. He also contributed as a Director for the Taipei Smart City IoT Association. His experience in reviewing medical policies for Taiwan’s FDA and involvement in mountain healthcare projects demonstrates his dedication to improving public health systems and addressing diverse healthcare needs through integrated solutions.

Awards and Honors

Dr. Chun-Feng Huang has received numerous accolades for his contributions to medicine and community health. He was recognized with the First Prize at the Annual Academic Conference by the Taiwan Association of Family Medicine in both 2011 and 2018. Between 2010 and 2017, he served as the Principal Investigator for key projects, including the Mountain and Offshore Healthcare Plan and healthcare services for correctional institutions. His leadership was also acknowledged as Chairman of the Yilan County Kang Tai Community Development Association and as Director of the Taipei Smart City IoT Association. His continuous service to healthcare is highlighted by his role as a reviewer for the Taiwan Food and Drug Administration. These awards and honors underscore his commitment to innovation, excellence in family medicine, and the advancement of public health initiatives.

Research Focus

Dr. Chun-Feng Huang’s research centers on metabolomics, precision medicine, gerontology, and osteoporosis. He explores the intricate connections between metabolic pathways and chronic diseases, aiming to develop personalized medical interventions. His work in precision medicine emphasizes tailoring treatments to individual genetic and environmental factors, particularly for elderly populations. In gerontology, he focuses on improving quality of life and functional health outcomes, with a special interest in sarcopenia and cognitive decline. Dr. Huang is also a leading expert in osteoporosis research, contributing to guidelines for fracture prevention and management. His studies include the effects of medications on bone health and the development of innovative treatments to reduce mortality in osteoporosis patients. Through multidisciplinary collaborations, he aims to bridge clinical research with practical healthcare solutions, advancing the understanding and management of age-related diseases.

Conclusion

Dr. Chun-Feng Huang is an outstanding candidate for the Best Researcher Award. His prolific research output, leadership roles, and clinical impact demonstrate excellence and dedication. Addressing the suggested areas for improvement could further elevate his contributions, but his current achievements already position him as a leading figure in his field.

Publication Top Notes

Nicotinuric acid: a potential marker of metabolic syndrome through a metabolomics-based approach

Authors: CF Huang, ML Cheng, CM Fan, CY Hong, MS Shiao

Citations: 57

Year: 2013

Effects of incorporating multidomain interventions into integrated primary care on quality of life: a randomised controlled trial

Authors: WJ Lee, LN Peng, CH Lin, RC Chen, SZ Lin, CH Loh, SL Kao, TS Hung, …

Citations: 55

Year: 2021

Heat stress responses modulate calcium regulations and electrophysiological characteristics in atrial myocytes

Authors: YC Chen, YH Kao, CF Huang, CC Cheng, YJ Chen, SA Chen

Citations: 38

Year: 2010

Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update

Authors: TW Tai, CF Huang, HK Huang, RS Yang, JF Chen, TT Cheng, FP Chen, …

Citations: 29

Year: 2023

Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study

Authors: TW Tai, CC Li, CF Huang, WP Chan, CH Wu

Citations: 24

Year: 2022

Mononucleated and binucleated cardiomyocytes in left atrium and pulmonary vein have different electrical activity and calcium dynamics

Authors: CF Huang, YC Chen, HI Yeh, SA Chen

Citations: 22

Year: 2012

Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women: Systemic review and meta-analysis

Authors: CH Wu, WC Hung, L Chang, TT Tsai, YF Chang, EV McCloskey, NB Watts, …

Citations: 19

Year: 2020

Retrospective study of the effects of zoledronic acid on muscle mass in osteoporosis patients

Authors: CF Huang, MS Shiao, TY Mao

Citations: 17

Year: 2021

Detection of ventilatory thresholds using near-infrared spectroscopy with a polynomial regression model

Authors: CW Lin, CF Huang, JS Wang, LL Fu, TY Mao

Citations: 15

Year: 2020

First insights on value-based healthcare of elders using ICHOM older person standard set reporting

Zhushanying Zhang | Health Professions | Best Researcher Award

Posted on 20/11/202420/11/2024 by ScienceFather

Assist. Prof. Dr. Zhushanying Zhang | Health Professions | Best Researcher Award

Assist. Prof. Dr. Zhushanying Zhang, South-Central Minzu University, China

Dr. Zhushanying Zhang holds a Ph.D. in Mechanical and Electronic Engineering from the School of Mechanical Science and Engineering, Huazhong University of Science and Technology. His research focuses on infrared spectroscopy detection, machine learning, optoelectronic detection, and fiber optic sensing. Dr. Zhang has led multiple National Natural Science Foundation of China-funded projects and received special funding for basic scientific research. He has published over ten academic papers and holds three invention patents. His work includes advancing Fourier infrared spectroscopy for noninvasive diabetes diagnosis through blood, urine, and saliva samples. 🔬📑💡

Publication Profile

Scopus

Academic and Professional Background

Assist. Prof. Dr. Zhushanying Zhang graduated with a Ph.D. in Mechanical and Electronic Engineering from the School of Mechanical Science and Engineering at Huazhong University of Science and Technology. His research focuses on infrared spectroscopy detection, machine learning, optoelectronic detection, and fiber optic sensing. Dr. Zhang has led and participated in several research projects funded by the National Natural Science Foundation of China, alongside special funding for basic scientific research from central universities. He has published over ten high-quality academic papers as the first or corresponding author and holds three invention patents. 📚💡📑

Research and Innovations

Assist. Prof. Dr. Zhushanying Zhang has led multiple innovative research projects focused on non-invasive detection technologies. His completed projects include the “Highly Accurate Glucose Detection Using Mid-Infrared Absorption Spectroscopy” (2022-2023, 50,000 Yuan) and “Non-invasive Uric Acid Detection by Near-Infrared Spectroscopy” (2018-2020, 40,000 Yuan), both funded by the Fundamental Research Funds for Central Universities. He also presided over the “Non-invasive Detector for Human Weak Components” (2021-2023, 100,000 Yuan) and “Human Saliva Infrared Spectroscopy Detection” (2022-2023, 500,000 Yuan). His work in Fourier infrared spectroscopy offers promising advancements for diabetes diagnosis using blood, urine, and saliva samples. 🧬📊

Research Areas

Assist. Prof. Dr. Zhushanying Zhang’s research spans across multiple cutting-edge fields. His expertise in infrared spectroscopy and fiber optic sensing focuses on non-invasive medical diagnostics, particularly for glucose and uric acid detection. Utilizing machine learning techniques, he enhances the accuracy and efficiency of sensor data analysis. His work in medical sensing aims to revolutionize healthcare by developing innovative detection technologies. Additionally, Dr. Zhang applies chemometrics to optimize data interpretation, advancing the potential of these technologies for real-world applications, especially in diagnostics and healthcare monitoring. 🔍💡📈

Publication Top Notes

“Advances in Fourier infrared spectroscopy for noninvasive diagnosis of diabetes mellitus: Analysis and prospects for application based on blood, urine, and saliva samples” (2024) 📄
“Precise measurement of human heart rate based on multi-channel radar data fusion” (2024) 📄
“A comprehensively improved local binary pattern framework for texture classification” (2024) 📄
“Identifying the Role of Disulfidptosis in Endometrial Cancer via Machine Learning Methods” (2023) 📄 | Cited by 1
“Quantitative Analysis of Hemoglobin Based on SiPLS-BP Model” (2023) 📄 | Cited by 2
“Texture classification combining improved local binary pattern and threshold segmentation” (2023) 📄 | Cited by 12
“Mid-infrared spectroscopy with an effective variable selection method based on MPA for glucose detection” (2023) 📄 | Cited by 5
“Influencing Factors of Mid-Infrared Spectrum Blood Glucose Detection” (2023) 📄 | Cited by 2
“Quantitative Analysis of Hemoglobin Based on SiPLS-SPA Wavelength Optimization” (2023) 📄 | Cited by 3
“Thermal performance of LED filament in flip-chip packaging manufactured for different correlated color temperature” (2021) 📄 | Cited by 1

Luis Sobrevia | Medicine and Dentistry | Best Researcher Award

Posted on 11/11/202411/11/2024 by ScienceFather

Prof. Luis Sobrevia | Medicine and Dentistry | Best Researcher Award

Prof. Luis Sobrevia, Pontificia Universidad Católica de Chile, Chile

Prof. Luis Sobrevia is a distinguished Chilean physiologist with extensive academic and research credentials. He completed his BSc in Biological Sciences from Universidad del Bío-Bío, MSc in Physiological Sciences from Universidad de Concepción, and PhD in Physiology and Biomedicine from King’s College London. He has held postdoctoral training at King’s College London and earned a Diploma in University Teaching from Pontificia Universidad Católica de Chile (PUC). As a Fellow of The Physiological Society (UK) and the International Union of Physiological Sciences, he holds prominent academic positions worldwide, including at PUC, TecSalud in Mexico, and UNESP in Brazil. His research focuses on placental vascular dysfunction in pregnancy complications like gestational diabetes and obesity, studying pathways that affect maternal-fetal health. He has mentored numerous PhD and MSc students and collaborates globally on groundbreaking research. 🌍🔬

Publication Profile

Google Scholar

Education

Prof. Luis Sobrevia holds a BSc Hons. in Biological Sciences (1986) from Universidad del Bío-Bío, Chile, and an MSc in Physiology (1990) from Universidad de Concepción, Chile. He earned his PhD in Physiology and Biomedicine (1996) at King’s College London, UK, followed by a postdoctoral fellowship there. Prof. Sobrevia has held academic positions globally, currently serving as a Distinguished Research Professor at Tecnológico de Monterrey, Mexico, and as an Honorary Professor in Australia, Spain, and Brazil. His extensive experience spans physiology, biomedicine, and university teaching, making significant contributions to obstetrics and biomedical sciences. 🏥📚

Research

Prof. Luis Sobrevia leads an extensive research group comprising PhD students from various global institutions, such as PUC Chile, U Talca, UNESP Brazil, and U Coimbra, Portugal. His team includes MSc and undergraduate students, along with technical research assistants like biochemist K Silva. The group hosts postdoctoral researchers, including A Grismaldo and MA Pascon. Collaborations span prestigious institutions like University Medical Centre Groningen, TecSalud, and Karolinska Institutet. As a thesis supervisor, Prof. Sobrevia has mentored 69 students across PhD, MSc, and undergraduate levels, focusing on physiology, biomedicine, and molecular biology. 🌍📚💡

Teaching Experience 🎓📚

Prof. Luis Sobrevia is a dedicated educator, teaching undergraduate courses in Medicine, Biology, Biochemistry, Nutrition, and Bioethics. He also mentors postgraduate students, including PhD, MSc, and medical specialization programs. His teaching spans top universities in Chile (PUC, UCH, UT, UA, UACH, UDEC) and internationally at institutions like UMCG (Netherlands), US (Spain), KCL (UK), AUT (New Zealand), UQCCR (Australia), UNESP (Brazil), and TecMonterrey (Mexico). His expertise covers topics such as gestational diabetes, fetal vascular dysfunction, cardiovascular pathophysiology, endothelial physiology, and insulin and adenosine signaling. 🌍🩺📖

Academic and Scientific Merit Recognitions 🌟🏅

Prof. Luis Sobrevia has earned numerous prestigious awards and appointments throughout his academic career. In 2024, he was nominated as a Corresponding Member of the Chilean Academy of Sciences and recognized for his contributions to internationalization by the Mexican Society of Physiological Sciences. He was also appointed Co-president of the Regional Focal Point for Latin America and the Caribbean (RFP-LAC) of the International Science Council (ISC) and Editor-in-Chief of Physiological Minireviews. His leadership extends to roles such as Regional Editor for The Journal of Physiology and member of international scientific committees, highlighting his significant global impact. 🌍📚💡

Publication Top Notes

Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells by GE Mann, DL Yudilevich, L Sobrevia, Physiological reviews 83 (1), 183-252, Cited by: 578, 2003 📚💉
A gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migration by C Salomon, MJ Torres, M Kobayashi, K Scholz-Romero, L Sobrevia, PloS one 9 (6), e98667, Cited by: 412, 2014 🤰🔬
Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis by C Salomon, J Ryan, L Sobrevia, M Kobayashi, K Ashman, M Mitchell, PloS one 8 (7), e68451, Cited by: 400, 2013 🌱💧
Oxidative stress: Normal pregnancy versus preeclampsia by DI Chiarello, C Abad, D Rojas, F Toledo, CM Vázquez, A Mate, Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (2), 165354, Cited by: 325, 2020 🩸💔
Hypoxia-induced changes in the bioactivity of cytotrophoblast-derived exosomes by C Salomon, M Kobayashi, K Ashman, L Sobrevia, MD Mitchell, GE Rice, PloS one 8 (11), e79636, Cited by: 213, 2013 🌍💫
Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia by L Sobrevia, GE Mann, Experimental Physiology: Translation and Integration 82 (3), 423-452, Cited by: 208, 1997 🧬🩺
Activation of L‐arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells by L Sobrevia, A Nadal, DL Yudilevich, GE Mann, The Journal of physiology 490 (3), 775-781, Cited by: 204, 1996 ⚡💡
Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy by SD Calligaris, M Lecanda, F Solis, M Ezquer, J Gutierrez, E Brandan, PloS one 8 (4), e60931, Cited by: 189, 2013 🍔❤️
Extracellular vesicles in obesity and diabetes mellitus by F Pardo, R Villalobos-Labra, B Sobrevia, F Toledo, L Sobrevia, Molecular aspects of medicine 60, 81-91, Cited by: 187, 2018 🧬🍩
Early activation of the p42/p44MAPK pathway mediates adenosine‐induced nitric oxide production in human endothelial cells: a novel calcium‐insensitive … by AW Wyatt, JR Steinert, CPD Wheeler‐Jones, AJ Morgan, D Sugden, The FASEB journal 16 (12), 1584-1594, Cited by: 155, 2002 🔬💡

HECTOR ABELARDO OCAMPO | Pharmaceutical Science | Excellence in Research

Posted on 30/10/202430/10/2024 by ScienceFather

Dr. HECTOR ABELARDO OCAMPO | Pharmaceutical Science | Excellence in Research

Dr. HECTOR ABELARDO OCAMPO, Instituto Politécnico Nacional, Mexico

Dr. Héctor Abelardo González Ocampo is a dedicated researcher and full-time professor at the Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional, focusing on sustainable aquaculture technologies. His innovative work includes developing microencapsulated phenolic extracts as antioxidant and immunostimulant additives in aquaculture diets. He holds several patents related to biotechnological additives and environmental impact. Dr. González supervises master’s and doctoral students in natural resource management and biotechnology, contributing significantly to academic development. His recent graduates have explored topics related to environmental health risks associated with marine species. 🌱🐟📚

Publication Profile

Google Scholar

Academic Experience and Contributions

Dr. Ocampo has a substantial teaching portfolio. He imparts knowledge in environmental impact and ecotoxicology to graduate students, thereby shaping the next generation of researchers in environmental sciences. His commitment to education ensures that his research impacts future leaders in sustainable practices and policies.

Conclusion

Dr. Héctor Abelardo Ocampo’s multifaceted expertise in sustainable aquaculture technologies, public health risk assessment, and his strong academic and patent record positions him as an exemplary candidate for the Research for Best Researcher Award. His work not only advances scientific knowledge but also contributes to practical solutions in environmental sustainability and public health safety, aligning perfectly with the award’s objectives.

Publication Top Notes

Las áreas naturales protegidas de México 🌳 | Cited by: 91 | Year: 2014
The prebiotic inulin increases the phenoloxidase activity and reduces the prevalence of WSSV in whiteleg shrimp (Litopenaeus vannamei) cultured under laboratory conditions 🍤 | Cited by: 77 | Year: 2012
Effect of inulin and probiotic bacteria on growth, survival, immune response, and prevalence of white spot syndrome virus (WSSV) in Litopenaeus vannamei 🦠 | Cited by: 57 | Year: 2013
Microbial immunostimulants reduce mortality in whiteleg shrimp (Litopenaeus vannamei) challenged with Vibrio sinaloensis strains ⚠️ | Cited by: 54 | Year: 2011
Mangrove forest and artisanal fishery in the southern part of the Gulf of California, Mexico 🌊 | Cited by: 51 | Year: 2013
Growth, survival, and superoxide dismutase activity in juvenile Crassostrea corteziensis (Hertlein, 1951) treated with probiotics 🦪 | Cited by: 44 | Year: 2009
Human health risk assessment of pesticide residues in snappers (Lutjanus) fish from the Navachiste Lagoon complex, Mexico ⚠️ | Cited by: 38 | Year: 2015
Protective effect of microbial immunostimulants and antiviral plants against WSSV in Litopenaeus vannamei cultured under laboratory conditions 🌱 | Cited by: 37 | Year: 2014
Dietary microorganism and plant effects on the survival and immune response of Litopenaeus vannamei challenged with the white spot syndrome virus 🍃 | Cited by: 35 | Year: 2011
Isolation and characterization of infectious Vibrio sinaloensis strains from the Pacific shrimp Litopenaeus vannamei (Decapoda: Penaeidae) 🔬 | Cited by: 34 | Year: 2012

Mahmoud Ramadan | Medicine and Dentistry | Outstanding Scientist Award

Posted on 05/10/202405/10/2024 by ScienceFather

Assoc Prof Dr. Mahmoud Ramadan | Medicine and Dentistry | Outstanding Scientist Award

Associate Professor at College of Medicine, University of Sharjah, United Arab Emirates

Dr. Mahmoud Ramadan is an accomplished Clinical Associate Professor with extensive expertise in cardiovascular medicine and cardiology. He holds a Doctorate in Cardiovascular Medicine from Niigata University, Japan, and has been involved in various academic and clinical roles, currently serving at both the University of Sharjah in the UAE and Mansoura University in Egypt. With multiple certifications in cardiology and significant research experience, including participation in the global INTERHEART study, Dr. Ramadan has contributed numerous publications to esteemed journals. His proficiency in statistical analysis, languages, and various medical certifications underscores his dedication to advancing cardiovascular health and education.

Publication profile

Scopus Profile

Education Background

Dr. Mahmoud Ramadan holds an extensive educational background in the field of medicine, particularly in cardiovascular medicine. He earned his Doctorate Degree in Cardiovascular Medicine from Niigata University Graduate School of Medical and Dental Sciences in Japan, graduating in September 2008. His doctoral thesis focused on the “Impact of Percutaneous Coronary Intervention on the Levels of Interleukin-6 and C-Reactive Protein in the Coronary Circulation of Subjects with Coronary Artery Disease.” Prior to this, he completed his Master’s degree in Cardiology at Mansoura University, Egypt, where he graduated in May 2001, and his undergraduate degree, M.B.B.Ch., from the same institution in November 1995, graduating with honors. Additionally, Dr. Ramadan has pursued further professional development, obtaining various certifications, including MRCP (UK) and other specialized courses in areas such as echocardiography, abdominal ultrasonography, and atherosclerosis, thereby reinforcing his expertise in the medical field.

Research Experience

Dr. Mahmoud Ramadan has extensive research experience in cardiovascular medicine, evidenced by his impactful work as a Clinical Associate Professor and multiple roles in renowned medical institutions. He earned his PhD from Niigata University, Japan, where he explored the effects of percutaneous coronary interventions on inflammatory markers in patients with coronary artery disease. His involvement in the global “INTERHEART” study significantly contributed to understanding myocardial infarction risk factors across various populations. Dr. Ramadan has published numerous original research articles in prestigious journals, focusing on topics such as cardiac dysfunction, coronary disease, and inflammatory responses, showcasing his dedication to advancing cardiovascular science. Additionally, he has supervised both master’s and PhD students, further demonstrating his commitment to fostering future research talent in the field.

Teaching and Mentoring Experience

Dr. Mahmoud Ramadan has extensive teaching and mentoring experience in the field of cardiology and medicine. As an Associate Professor of Medicine at the University of Sharjah and the Faculty of Medicine at Mansoura University, he has contributed significantly to the education of medical students and residents. He has lectured on various topics in cardiology, sharing his expertise and fostering critical thinking among students. Additionally, Dr. Ramadan has supervised numerous master’s and PhD students, guiding them through their research projects and dissertations, which demonstrates his commitment to nurturing the next generation of medical professionals. His role as an AHA-certified instructor in Advanced Cardiovascular Life Support (ACLS) and Basic Life Support (BLS) further underscores his dedication to teaching practical skills that are essential in clinical settings. Through his mentorship and teaching, he has played a vital role in shaping the educational landscape in cardiology, emphasizing the importance of both theoretical knowledge and hands-on experience.

Work Experience

Dr. Mahmoud Ramadan has an extensive work experience in the field of cardiology and medicine, spanning over two decades. He currently serves as an Associate Professor of Medicine in the Clinical Sciences Department at the University of Sharjah, UAE, and holds a similar position at Mansoura University in Egypt. His professional journey began as a House Officer at Mansoura University Hospitals, followed by various roles including Resident Physician, Assistant Lecturer, and Lecturer in Cardiology at Mansoura University. Throughout his career, he has engaged in advanced clinical training in Japan and contributed significantly to teaching, supervision, and research in cardiovascular medicine. Additionally, Dr. Ramadan is involved in multiple professional certifications, training programs, and has contributed to several international collaborative studies, showcasing his commitment to advancing medical knowledge and practice in cardiology.

Awards, Honours & Certificates

Dr. Mahmoud Ramadan has received several prestigious awards and honors throughout his academic and professional career. Notably, he was selected as a representative of Mansoura University in the global INTERHEART study, which was published in The Lancet. He also earned the esteemed Japanese Government Monbu-Kagakusho Scholarship for his PhD in Cardiology from Niigata University. In addition, Dr. Ramadan was recognized as a Young Investigator Award Finalist at the 22nd Annual Meeting of the Japanese Section of the International Society of Heart Research. His accolades include the EJISST Award at the First Egypt-Japan International Symposium on Science and Technology and the JSPS Post-Doctoral Fellowship from the Japan Society for the Promotion of Science in 2008. His commitment to continued education is evidenced by his completion of various certifications, including in mechanical ventilation and echocardiography, as well as his membership in several distinguished medical associations.

Publication Top Notes

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
- Authors: Brauer, M., Roth, G.A., Aravkin, A.Y., Murray, C.J.L., Gakidou, E.
- Year: 2024
- Citations: 66
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
- Authors: Ferrari, A.J., Santomauro, D.F., Aali, A., Vos, T., Murray, C.J.L.
- Year: 2024
- Citations: 107
Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement
- Authors: Alsereidi, F.R., Khashim, Z., Marzook, H., Ramadan, M.M., Saleh, M.A.
- Year: 2024
- Citations: 4
Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
- Authors: Sirota, S.B., Doxey, M.C., Dominguez, R.-M.V., Murray, C.J.L., Kyu, H.H.
- Year: 2024
- Citations: 1
Alchemilla vulgaris modulates isoproterenol-induced cardiotoxicity: interplay of oxidative stress, inflammation, autophagy, and apoptosis
- Authors: Anajirih, N., Abdeen, A., Taher, E.S., Ramadan, M.M., Habotta, O.A.
- Year: 2024
- Citations: 0

Conclusion

Dr. Mahmoud Ramadan exemplifies the qualities of an outstanding researcher in cardiovascular medicine. His strong academic background, extensive research contributions, and clinical expertise make him a deserving candidate for the Best Researcher Award. By focusing on expanding his research scope, increasing outreach, diversifying research methodologies, and embracing innovative trends, he can further enhance his impact in the field. Awarding him this recognition would not only honor his past contributions but also encourage future advancements in cardiovascular research and patient care.

Gopal Natesan | Medicinal Chemistry | Best Researcher Award

Posted on 21/09/202421/09/2024 by ScienceFather

Prof Dr. Gopal Natesan | Medicinal Chemistry | Best Researcher Award

Prof Dr. Gopal Natesan, Institute of Pharmacy, Nirma University, India

Prof. Dr. Gopal Natesan is a distinguished academic and researcher in pharmaceutical chemistry, currently serving as Professor & Director at the Institute of Pharmacy, Nirma University, India. He holds a Ph.D. from Hamdard University and an MBA from MAHSA University. His research focuses on the synthesis of biologically active compounds and pharmacological evaluations. Dr. Natesan has received numerous accolades, including the “Most Trusted & Innovative Researcher in Asia” award in 2023 and the “Outstanding Scientist Award” in 2022. With a strong industrial background, he promotes research innovation and academic excellence. 🧪📚

Publication profile

Google Scholar

Educational Qualifications

Prof. Dr. Gopal Natesan boasts an impressive educational background. He earned his Ph.D. in Pharmaceutical Chemistry from Hamdard University in 2001. He also holds an M. Pharmacy from JSS College of Pharmacy (1996) and a B. Pharmacy from JKK Nataraja College of Pharmacy (1993), both affiliated with The Tamilnadu Dr. MGR Medical University. In 2016, he completed a Post Graduate Certificate in Teaching & Learning at Anglia Ruskin University, UK, and became a Fellow of The Higher Education Academy. Most recently, he obtained an MBA from MAHSA University in 2022. 📚🔬

Honors & Awards

Prof. Dr. Gopal Natesan has received numerous prestigious awards for his contributions to pharmaceutical science and education. In 2023, he was honored as the “Most Trusted & Innovative Researcher in Asia” at the ASIA-GCC Awards. His accolades include the “Outstanding Scientist Award” in 2022 and the “Edward Kennedy Memorial Award” in 2017. He has also received multiple best presentation and paper awards at international conferences, reflecting his commitment to excellence in research. Additionally, he was recognized with a Vice-Chancellor Award for outstanding performance in his MBA program, showcasing his academic prowess. 🌟🎓

Employment History

Prof. Dr. Gopal Natesan has served as Professor and Director at the Institute of Pharmacy, Nirma University, Ahmedabad, India. In this role, he manages operational activities, ensuring efficient administration and resource utilization. He oversees academic programs, maintaining high standards in teaching and curriculum development. Dr. Natesan is dedicated to faculty development, fostering continuous learning and research engagement. He enhances student experiences through support services and extracurricular activities while ensuring quality assurance through compliance with academic standards. Additionally, he promotes research innovation by securing grants and encouraging collaborations with industry and academia. 🌟🔬

Industrial Experience

Prof. Dr. Gopal Natesan has valuable industrial experience in the pharmaceutical sector. From November 2000 to January 2002, he worked as a Research Scientist at Ranbaxy Research Laboratory in Gurgoan, New Delhi, where he contributed to innovative pharmaceutical research. Following this, he served as a Research Associate at Orchid Chemicals & Pharmaceuticals Ltd in Chennai from January 2002 to February 2004. In these roles, he developed essential skills in research methodologies and project management, further enhancing his expertise in medicinal chemistry and pharmaceutical sciences. His industrial background complements his academic leadership, bridging theory and practice. 💼✨

Research Interests

Prof. Dr. Gopal Natesan specializes in medicinal chemistry, focusing on the synthesis and characterization of biologically active new chemical entities with five or six-member heterocyclic ring systems. His research includes the pharmacological evaluation of synthesized compounds, ensuring their potential therapeutic applications. Additionally, he is dedicated to the isolation and characterization of active constituents from plant sources, highlighting the importance of natural products in drug discovery. Dr. Natesan also explores pharmaceutical marketing management, integrating scientific research with practical applications in the pharmaceutical industry. 🌱💊

Publication Top Notes

Hepatoprotective activity of Clerodendrum inerme against CCl4 induced hepatic injury in rats – Cited by: 85, Year: 2008 📄
Simultaneous estimation of paracetamol and aceclofenac in combined dosage forms by RP-HPLC method – Cited by: 44, Year: 2007 💊
Synthesis and Antibacterial Activity of Some Imidazole‐5‐(4H)one Derivatives – Cited by: 32, Year: 2005 🦠
Synthesis, characterization and antimicrobial activity of some novel Schiff and Mannich bases of isatin – Cited by: 22, Year: 2014 ✨
Antipyretic and analgesic effects of the aqueous extracts of Prosopis cineraria – Cited by: 22, Year: 2011 🌿
Quantitative estimation of lopinavir and ritonavir in tablets by RP-HPLC method – Cited by: 19, Year: 2012 💊
Simultaneous estimation of levocetirizine, ambroxol, phenylpropanolamine and paracetamol in combined dosage forms by RP-HPLC method – Cited by: 17, Year: 2006 📊
Anti-inflammatory activity of newly synthesised N-[4’-Oxo-2’-(substituted aryl/heteryl)-thiazolidin-3’-yl]-3-carboxamido-2H-chromen-2-one derivatives – Cited by: 15, Year: 2011 🔍
UV-Spectrophotometric Determination of Esomeprazole in tablet dosage forms – Cited by: 14, Year: 2007 💡
Effect of pollen substitute and two queen system on royal jelly production in Apis Mellifera L – Cited by: 13, Year: 1996 🐝
A validated HPTLC method for the estimation of donepezil HCL in bulk and its tablet dosage form – Cited by: 12, Year: 2011 ✔️
Synthesis and anticonvulsant activity of new 2-(substituted aryl/heteryl)-3-(substituted arylidenimino)-6, 8-dibromo-1, 2, 3, 4-tetrahydroquinazolin-4 (3H)-one derivatives – Cited by: 12, Year: 2006 ⚡
Synthesis and pharmacological evaluation of some indanone-3-acetic acid derivatives – Cited by: 11, Year: 2006 📈
UV spectrophotometric determination of famciclovir – Cited by: 10, Year: 2007 📊
Simultaneous determination of lafutadine and domperidone in capsule by high performance liquid chromatography – Cited by: 9, Year: 2012 💼